Organisation
Department of Pharmaceutics
Department
Current researchers
31 - 40 of 120 results
- Sarah De Keulenaer (Member)
- Emily De Lombaerde (Member)
- Ellen De Meester (Member)
- Kristien De Paepe (Member)
- Elisa De Pauw (Member)
- Stefaan De Smedt (Member)
- Margo De Velder (Member)
- Lotte De Wever (Member)
- Aliona Debisschop (Member)
- Ann Debunne (Member)
Projects
31 - 40 of 375
- Laser-induced nanobubbles for advanced therapies in the eyeFrom1 Sep 2023 → TodayFunding: BOF - projects
- Pulsed Laser Light and Nano-encapsulated Ocular Dyes for Advanced Therapies in the EyeFrom1 Sep 2023 → TodayFunding: Horizon Europe - European Research Council (ERC)
- Novel photosensitizers to push the limits of photodynamic cancer therapyFrom14 Aug 2023 → TodayFunding: IOF - technology concept exploration
- Increasing the value proposition of the IOF programs CRISParray and Amalus: CRISPRi-based target deconvolution of fibroblast modulatorsFrom15 Jul 2023 → TodayFunding: IOF - technology validation in lab
- Identification of optimized Aurora Kinase A PROTACs with suitable PK properties for in vivo proof-of-concept studies (OPTIMAPK).From15 Jul 2023 → TodayFunding: IOF - technology concept exploration
- Postdoctoral Fellowship Program in National Glaucoma Research: "“Exploring ICG-mediated ILM photodisruption as a tool to boost retinal ganglion cell engraftment"From1 Jul 2023 → TodayFunding: Foreign private sponsor - undefined
- Immunopeptidomics-based Development of Next-Generation Bacterial mRNA VaccinesFrom1 Jul 2023 → TodayFunding: HORIZON.2.1 - Health
- TARgeted Mrna re-engineering for enhanced Antibody and Cellular immunity (TARMAC)From15 Apr 2023 → 14 Apr 2024Funding: IOF - technology concept exploration
- New antivirals against human parainfluenza virusFrom1 Apr 2023 → TodayFunding: IOF - technology validation in lab
- A Belgian representation on the Scientific Advice Working Party (SAWP) of the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA).From1 Mar 2023 → TodayFunding: FOD Public Health, Safety of the food chain and the Environment
Publications
1 - 10 of 1924
- Reslizumab in eosinophilic asthma : a review(2017)
Authors: Emma D Deeks, Guy Brusselle
Pages: 777 - 784 - Cluster analysis of inflammatory biomarker expression in the international severe asthma registry(2021)
Authors: Eve Denton, David B. Price, Trung N. Tran, G. Walter Canonica, Andrew Menzies-Gow, J. Mark FitzGerald, Mohsen Sadatsafavi, Luis Perez de Llano, George Christoff, Anna Quinton, et al.
Pages: 2680 - 2688.e7 - Early origins of chronic obstructive lung diseases across the life course(2014)
Authors: Liesbeth Duijts, Irwin K Reiss, Guy Brusselle, Johan C de Jongste
Pages: 871 - 885 - Matrix Metalloproteinase 12, Asthma, and COPD(2009)
Authors: Guy Brusselle
Pages: 2664 - 2665 - Recent advances in chronic obstructive pulmonary disease pathogenesis : from disease mechanisms to precision medicine(2020)
Authors: Corry-Anke Brandsma, Maarten Van den Berge, Tillie-Louise Hackett, Guy Brusselle, Wim Timens
Pages: 624 - 635 - Global Initiative for Asthma Strategy 2021 : executive summary and rationale for key changes(2022)
Authors: Helen K. Reddel, Leonard B. Bacharier, Eric D. Bateman, Christopher E. Brightling, Guy Brusselle, Roland Buhl, Alvaro A. Cruz, Liesbeth Duijts, Jeffrey M. Drazen, J. Mark FitzGerald, et al.
Pages: 14 - 35 - Real-life effectiveness of mepolizumab in severe asthma : a systematic literature review(2022)
Authors: Elliot Israel, Giorgio Walter Canonica, Guy Brusselle, Shibing Yang, Peter H. Howarth, Amber L. Martin, Maria Koufopoulou, Steven G. Smith, Rafael Alfonso-Cristancho
Pages: 2201 - 2217 - Efficacy and safety of once-daily single-inhaler triple therapy (FF/UMEC/VI) versus FF/VI in patients with inadequately controlled asthma (CAPTAIN) : a double-blind, randomised, phase 3A trial(2021)
Authors: Laurie A Lee, Zelie Bailes, Neil Barnes, Louis-Philippe Boulet, Dawn Edwards, Andrew Fowler, Nicola A Hanania, Huib A M Kerstjens, Edward Kerwin, Robert Nathan, et al.
Pages: 69 - 84 - The risk of new onset heart failure associated with dopamine agonist use in Parkinson's disease(2012)
Authors: M Mostafa Mokhles, Gianluca Trifirò, Jeanne P Dieleman, Mendel D Haag, Eva M van Soest, Katia MC Verhamme, Giampiero Mazzaglia, Ron Herings, Cynthia de Luise, Douglas Ross, et al.
Pages: 358 - 364 - Treatable traits : toward precision medicine of chronic airway diseases(2016)
Authors: Alvar Agusti, Elisabeth Bel, Mike Thomas, Claus Vogelmeier, Guy Brusselle, Stephen Holgate, Marc Humbert, Paul Jones, Peter G Gibson, Jørgen Vestbo, et al.
Pages: 410 - 419